By Elsevier Business Intelligence

closed 11/7/2013 via BNC Analysis

Informa Healthcare, acquired Elsevier Business Intelligence

See 258 Comparable Transactions
synopsis: Informa plc has acquired Elsevier Business Intelligence. Elsevier Business Intelligence was cobbled together from previous Elsevier acquisitions—F-D-C Reports, Inc. in 1994 and Windhover Information, Inc. in 2008. It publishes some of the most prestigious newsletters for the healthcare industry.
buyer parent: Informa plc
buyer: Informa Healthcare
Informa Healthcare is a medical and scientific publisher whose goal is to connect librarians, scientists, professionals and other medical practicioners with information they can trust and see through a comprehensive portfolio of journals, print and online books, encyclopedias and directories. "
 target parent: Reed Elsevier
target: Elsevier Business Intelligence
Elsevier Business Intelligence, a global leader in the field of healthcare industry information, provides business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. It provides publications, conferences, databases and reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2013 via BNC Analysis

Informa Healthcare, acquired Elsevier Business Intelligence

See 258 Comparable Transactions
synopsis: Informa plc has acquired Elsevier Business Intelligence. Elsevier Business Intelligence was cobbled together from previous Elsevier acquisitions—F-D-C Reports, Inc. in 1994 and Windhover Information, Inc. in 2008. It publishes some of the most prestigious newsletters for the healthcare industry.
buyer parent: Informa plc
buyer: Informa Healthcare
Informa Healthcare is a medical and scientific publisher whose goal is to connect librarians, scientists, professionals and other medical practicioners with information they can trust and see through a comprehensive portfolio of journals, print and online books, encyclopedias and directories. "
 target parent: Reed Elsevier
target: Elsevier Business Intelligence
Elsevier Business Intelligence, a global leader in the field of healthcare industry information, provides business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. It provides publications, conferences, databases and reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

See 112 Comparable Transactions
synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$964.58)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
 target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

See 90 Comparable Transactions
synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
 target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/8/2017 via GlobeNewswire

PRA Health Sciences, will acquire Symphony Health Solutions

See 171 Comparable Transactions
synopsis: PRA Health Sciences, Inc. (“PRA”), a leading clinical research organization, announced it has signed a definitive agreement to acquire Symphony Health Solutions Corporation (“Symphony Health”), a privately-held best-in-class provider of data, analytics and consulting solutions to the life sciences market.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences is one of the world’s leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
 target parent: Symphony Technology Group
target: Symphony Health Solutions
Symphony Health Solutions is a leading provider of high-value data, analytics, and technology solutions for biopharmaceutical manufacturers, healthcare providers, and payers. Symphony Health derived data improves health management decisions, and helps clients drive revenue growth.
price ($mm)
$530
rev ($mm)
$200
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

See 50 Comparable Transactions
synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
 target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Affinity Equity Partners, will acquire MedicalDirector

See 831 Comparable Transactions
synopsis: Leading Asian private equity firm Affinity Equity Partners agreed to acquire Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
 target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

See 84 Comparable Transactions
synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
 target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

See 89 Comparable Transactions
synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
 target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 6/1/2011 via PR Newswire

Wolters Kluwer Health, acquired Lexi-Comp, Inc.

See 115 Comparable Transactions
synopsis: Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry, has completed its acquisition of Lexi-Comp, Inc., a leading global provider of drug information and clinical content for pharmacists and clinicians.
buyer parent: Wolters Kluwer NV
buyer: Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Its customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. "
 target: Lexi-Comp, Inc.
Lexicomp is an industry-leading provider of drug information and clinical content for the healthcare industry. The company provides the tools necessary to help improve patient safety, ensure compliance, and elevate the quality of care patients receive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

See 23 Comparable Transactions
synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
 target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/21/2010 via Company Press Release

MedMeme LLC, acquired Medical Intelligence Solutions

See 95 Comparable Transactions
synopsis: MedMeme, LLC, a leading provider of key opinion leader data and competitive intelligence to the healthcare, pharmaceutical, and biotechnical industries, announced the recent acquisition of Medical Intelligence Solutions (MIS), the world's foremost provider of information on medical meeting content.
buyer: MedMeme LLC
MedMeme™ LLC is a medical opinion leader database company serving the pharmaceutical and biotech community worldwide. MedMeme focuses on providing in-depth, comprehensive, accurate, and actionable competitive intelligence on all aspects of medical research and the experts who work in the field. "
 target: Medical Intelligence Solutions
Medical Intelligence Solutions (MIS) provides key clinical data presented at domestic and international medical meetings relevant to the development and marketing of pharmaceuticals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2008 via BtoBonline.com

Gemini Healthcare, LLC, acquired MCM Group

See 46 Comparable Transactions
synopsis: Marketing agency Gemini Healthcare has acquired MCM Group, a data analytics and benchmarking applications provider. Financial terms of the deal were not disclosed. MCM Group delivers its benchmarks programs through a proprietary platform called Total Resource Utilization that will now be available to Gemini's clients.
buyer: Gemini Healthcare, LLC
Gemini Healthcare, LLC is a healthcare marketing company based in Westbrook, Connecticut. "
 target: MCM Group
The MCM Group is a healthcare communications organization. We deliver comprehensive marketing, communications and consulting solutions for pharmaceutical and biotech companies. What's uncommon about us? Superior insight.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2008 via Company Press Release

Advanstar Communications Inc., acquired CBI Research, Inc.

See 61 Comparable Transactions
synopsis: Advanstar Communications, Inc. - a leading worldwide media company - today acquired CBI Research, Inc., a provider of live and electronic conferences for senior-level executives in the pharmaceutical and biotech industries.
buyer parent: Veronis Suhler Stevenson
buyer: Advanstar Communications Inc.
Advanstar Communications Inc. is a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries. "
 target: CBI Research, Inc.
CBI (aka The Center For Business Intelligence) is a world-class conference company that focuses on producing high-level programs for executive decision-makers who face strategic issues in domestic and international markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

See 63 Comparable Transactions
synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
 target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

See 156 Comparable Transactions
synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
 target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/30/2007 via Company Press Release

Entelos Inc., acquired Iconix Biosciences, Inc.

See 95 Comparable Transactions
synopsis: Entelos, Inc., a leading life sciences company that leverages its proprietary in silico disease models, known as PhysioLab® platforms, to develop drugs and support pharmaceutical R&D, is pleased to announce that it has entered into an agreement to acquire Iconix Biosciences, Inc., a privately held predictive toxicology company
buyer: Entelos Inc.
Entelos partners with pharmaceutical and biotech organizations worldwide to develop effective new treatments for disease and dramatically reduce the time and cost needed to develop them. Using our patented PhysioLab technology, Entelos develops dynamic large-scale computer models of human disease. "
 target: Iconix Biosciences, Inc.
Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix®)
price ($mm)
$7.73
rev ($mm)
$5
EBITDA ($mm)
EV / rev
6.7x
EV / EBITDA
closed 4/25/2006 via PR Newswire

Thomson Pharma, acquired CMR International

See 95 Comparable Transactions
synopsis: The Thomson Corporation today announced that it has completed the acquisition of Centre for Medicines Research International (CMR), the foremost provider of R&D performance metrics to the global pharmaceutical industry. CMR International, based in Epsom in the United Kingdom, is the world leader in global R&D performance measurement.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
 target: CMR International
CMR International is the foremost provider of R&D performance metrics to the global pharmaceutical industry. Our ‘gold standard’ reputation in this field is based on an unrivalled record of assuring the confidentiality of the data we manage and analyse.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

See 52 Comparable Transactions
synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
 target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/18/2016 via PR Newswire

C4 Recovery Solutions, Inc., acquired The Evolution of Addiction Treatment

See 34 Comparable Transactions
synopsis: C4 Recovery Solutions, Inc., a globally-recognized educational leader in the addiction and substance abuse treatment arena, announced a partnership and acquisition of the California-based conference, The Evolution of Addiction Treatment. The Evolution of Addiction Treatment is a bi-annual conference focusing on drug treatment and addiction.
buyer: C4 Recovery Solutions, Inc.
C4 Recovery Solutions, is a non-profit organization dedicated to promoting accountability-based treatment services, increasing access to treatment, and educating and training addiction treatment professionals. "
 target parent: Serene Recovery Network
target: The Evolution of Addiction Treatment
The mission of The Evolution of Addiction Treatment is to bring innovative and forward thinking treatment concepts combined with experiential education methods in order to propel the efficacy of addiction treatment forward.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

See 83 Comparable Transactions
synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
 target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
closed 11/7/2013 via BNC Analysis

Informa Healthcare, acquired Elsevier Business Intelligence

See 258 Comparable Transactions
synopsis: Informa plc has acquired Elsevier Business Intelligence. Elsevier Business Intelligence was cobbled together from previous Elsevier acquisitions—F-D-C Reports, Inc. in 1994 and Windhover Information, Inc. in 2008. It publishes some of the most prestigious newsletters for the healthcare industry.
buyer parent: Informa plc
buyer: Informa Healthcare
Informa Healthcare is a medical and scientific publisher whose goal is to connect librarians, scientists, professionals and other medical practicioners with information they can trust and see through a comprehensive portfolio of journals, print and online books, encyclopedias and directories. "
 target parent: Reed Elsevier
target: Elsevier Business Intelligence
Elsevier Business Intelligence, a global leader in the field of healthcare industry information, provides business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. It provides publications, conferences, databases and reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

See 112 Comparable Transactions
synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$964.58)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
 target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

See 90 Comparable Transactions
synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
 target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/8/2017 via GlobeNewswire

PRA Health Sciences, will acquire Symphony Health Solutions

See 171 Comparable Transactions
synopsis: PRA Health Sciences, Inc. (“PRA”), a leading clinical research organization, announced it has signed a definitive agreement to acquire Symphony Health Solutions Corporation (“Symphony Health”), a privately-held best-in-class provider of data, analytics and consulting solutions to the life sciences market.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences is one of the world’s leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
 target parent: Symphony Technology Group
target: Symphony Health Solutions
Symphony Health Solutions is a leading provider of high-value data, analytics, and technology solutions for biopharmaceutical manufacturers, healthcare providers, and payers. Symphony Health derived data improves health management decisions, and helps clients drive revenue growth.
price ($mm)
$530
rev ($mm)
$200
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

See 50 Comparable Transactions
synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
 target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Affinity Equity Partners, will acquire MedicalDirector

See 831 Comparable Transactions
synopsis: Leading Asian private equity firm Affinity Equity Partners agreed to acquire Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
 target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

See 84 Comparable Transactions
synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
 target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

See 89 Comparable Transactions
synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
 target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 6/1/2011 via PR Newswire

Wolters Kluwer Health, acquired Lexi-Comp, Inc.

See 115 Comparable Transactions
synopsis: Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry, has completed its acquisition of Lexi-Comp, Inc., a leading global provider of drug information and clinical content for pharmacists and clinicians.
buyer parent: Wolters Kluwer NV
buyer: Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Its customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. "
 target: Lexi-Comp, Inc.
Lexicomp is an industry-leading provider of drug information and clinical content for the healthcare industry. The company provides the tools necessary to help improve patient safety, ensure compliance, and elevate the quality of care patients receive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

See 23 Comparable Transactions
synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
 target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/21/2010 via Company Press Release

MedMeme LLC, acquired Medical Intelligence Solutions

See 95 Comparable Transactions
synopsis: MedMeme, LLC, a leading provider of key opinion leader data and competitive intelligence to the healthcare, pharmaceutical, and biotechnical industries, announced the recent acquisition of Medical Intelligence Solutions (MIS), the world's foremost provider of information on medical meeting content.
buyer: MedMeme LLC
MedMeme™ LLC is a medical opinion leader database company serving the pharmaceutical and biotech community worldwide. MedMeme focuses on providing in-depth, comprehensive, accurate, and actionable competitive intelligence on all aspects of medical research and the experts who work in the field. "
 target: Medical Intelligence Solutions
Medical Intelligence Solutions (MIS) provides key clinical data presented at domestic and international medical meetings relevant to the development and marketing of pharmaceuticals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2008 via BtoBonline.com

Gemini Healthcare, LLC, acquired MCM Group

See 46 Comparable Transactions
synopsis: Marketing agency Gemini Healthcare has acquired MCM Group, a data analytics and benchmarking applications provider. Financial terms of the deal were not disclosed. MCM Group delivers its benchmarks programs through a proprietary platform called Total Resource Utilization that will now be available to Gemini's clients.
buyer: Gemini Healthcare, LLC
Gemini Healthcare, LLC is a healthcare marketing company based in Westbrook, Connecticut. "
 target: MCM Group
The MCM Group is a healthcare communications organization. We deliver comprehensive marketing, communications and consulting solutions for pharmaceutical and biotech companies. What's uncommon about us? Superior insight.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2008 via Company Press Release

Advanstar Communications Inc., acquired CBI Research, Inc.

See 61 Comparable Transactions
synopsis: Advanstar Communications, Inc. - a leading worldwide media company - today acquired CBI Research, Inc., a provider of live and electronic conferences for senior-level executives in the pharmaceutical and biotech industries.
buyer parent: Veronis Suhler Stevenson
buyer: Advanstar Communications Inc.
Advanstar Communications Inc. is a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries. "
 target: CBI Research, Inc.
CBI (aka The Center For Business Intelligence) is a world-class conference company that focuses on producing high-level programs for executive decision-makers who face strategic issues in domestic and international markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

See 63 Comparable Transactions
synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
 target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

See 156 Comparable Transactions
synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
 target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/30/2007 via Company Press Release

Entelos Inc., acquired Iconix Biosciences, Inc.

See 95 Comparable Transactions
synopsis: Entelos, Inc., a leading life sciences company that leverages its proprietary in silico disease models, known as PhysioLab® platforms, to develop drugs and support pharmaceutical R&D, is pleased to announce that it has entered into an agreement to acquire Iconix Biosciences, Inc., a privately held predictive toxicology company
buyer: Entelos Inc.
Entelos partners with pharmaceutical and biotech organizations worldwide to develop effective new treatments for disease and dramatically reduce the time and cost needed to develop them. Using our patented PhysioLab technology, Entelos develops dynamic large-scale computer models of human disease. "
 target: Iconix Biosciences, Inc.
Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix®)
price ($mm)
$7.73
rev ($mm)
$5
EBITDA ($mm)
EV / rev
6.7x
EV / EBITDA
closed 4/25/2006 via PR Newswire

Thomson Pharma, acquired CMR International

See 95 Comparable Transactions
synopsis: The Thomson Corporation today announced that it has completed the acquisition of Centre for Medicines Research International (CMR), the foremost provider of R&D performance metrics to the global pharmaceutical industry. CMR International, based in Epsom in the United Kingdom, is the world leader in global R&D performance measurement.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
 target: CMR International
CMR International is the foremost provider of R&D performance metrics to the global pharmaceutical industry. Our ‘gold standard’ reputation in this field is based on an unrivalled record of assuring the confidentiality of the data we manage and analyse.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

See 52 Comparable Transactions
synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
 target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/18/2016 via PR Newswire

C4 Recovery Solutions, Inc., acquired The Evolution of Addiction Treatment

See 34 Comparable Transactions
synopsis: C4 Recovery Solutions, Inc., a globally-recognized educational leader in the addiction and substance abuse treatment arena, announced a partnership and acquisition of the California-based conference, The Evolution of Addiction Treatment. The Evolution of Addiction Treatment is a bi-annual conference focusing on drug treatment and addiction.
buyer: C4 Recovery Solutions, Inc.
C4 Recovery Solutions, is a non-profit organization dedicated to promoting accountability-based treatment services, increasing access to treatment, and educating and training addiction treatment professionals. "
 target parent: Serene Recovery Network
target: The Evolution of Addiction Treatment
The mission of The Evolution of Addiction Treatment is to bring innovative and forward thinking treatment concepts combined with experiential education methods in order to propel the efficacy of addiction treatment forward.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

See 83 Comparable Transactions
synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
 target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  

By Elsevier Business Intelligence


read more

Elsevier Business Intelligence

read more

Elsevier Business Intelligence

Decision Resources Group

Dymaxium, Inc.

Symphony Health Solutions

Vidal Group

MedicalDirector

Avalere Health LLC

Decision Resources Group

Lexi-Comp, Inc.

Edital

Medical Intelligence Solutions

MCM Group

CBI Research, Inc.

Prous Science

Infinata, Inc.

Iconix Biosciences, Inc.

CMR International

Pharmaspectra

The Evolution of Addiction Treatment

SpringerProtocols

Pages:  
read more

Elsevier Business Intelligence

Decision Resources Group

Dymaxium, Inc.

Symphony Health Solutions

Vidal Group

MedicalDirector

Avalere Health LLC

Decision Resources Group

Lexi-Comp, Inc.

Edital

Medical Intelligence Solutions

MCM Group

CBI Research, Inc.

Prous Science

Infinata, Inc.

Iconix Biosciences, Inc.

CMR International

Pharmaspectra

The Evolution of Addiction Treatment

SpringerProtocols

Pages:  
Geography
Matching Companies
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: HSTM
 
 
 
 
 
 
 
 
HealthStream, Inc.
HealthStream, Inc.
HealhStream’s unified suite of software-as-a-service solutions is contracted by, collectively, over 4.1 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, performance assessment, and managing simulation-based education programs.
year
2019
rev ($mm)
$254.11
EBITDA ($mm)
$31.65
EBIT ($mm)
$14.78
Net Income ($mm)
$15.77
Employees
863
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker: OM:SUS
 
 
 
 
 
 
 
 
Surgical Science
Surgical Science is a Swedish supplier of virtual reality simulators for medical training. Their training systems for laparoscopy and endoscopy are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
year
2019
rev ($mm)
$7.20
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.46)
Net Income ($mm)
Employees
20
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2019
rev ($mm)
$964.58
EBITDA ($mm)
$154.61
EBIT ($mm)
($47.97)
Net Income ($mm)
Employees
4515
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: HSTM
 
 
 
 
 
 
 
 
HealthStream, Inc.
HealthStream, Inc.
HealhStream’s unified suite of software-as-a-service solutions is contracted by, collectively, over 4.1 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, performance assessment, and managing simulation-based education programs.
year
2019
rev ($mm)
$254.11
EBITDA ($mm)
$31.65
EBIT ($mm)
$14.78
Net Income ($mm)
$15.77
Employees
863
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker: OM:SUS
 
 
 
 
 
 
 
 
Surgical Science
Surgical Science is a Swedish supplier of virtual reality simulators for medical training. Their training systems for laparoscopy and endoscopy are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
year
2019
rev ($mm)
$7.20
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.46)
Net Income ($mm)
Employees
20
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2019
rev ($mm)
$964.58
EBITDA ($mm)
$154.61
EBIT ($mm)
($47.97)
Net Income ($mm)
Employees
4515
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch